Studying a new way to reduce risks during early stomach cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are scheduled to have an ESD procedure for early stomach cancer that is eligible under standard guidelines.
- You have not had any prior treatment (like surgery or chemotherapy) on your stomach.
- Your recent blood tests show a platelet count above 10×10^9/L and hemoglobin above 8.0 g/L.
- You have stopped taking any blood-thinning medications for the recommended time before the procedure.
- You are able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new technique called RDI mode, which may help doctors remove early-stage tumors from the esophagus, stomach, or colon more safely. If you have a small early tumor or polyp, this study could help determine if the new method works better and has fewer complications.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
This study compares two approaches after a non-curative ESD for early stomach cancer: one that removes sentinel lymph nodes (the first nodes where cancer might spread) and one that does not. Participating may help find out if removing these nodes improves outcomes.
This trial compares two ways to treat early stomach cancer: removing it through an endoscope versus doing an operation. It’s meant for a specific stomach-cancer type (undifferentiated) that has not spread, to see which approach may be better.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This study tests whether adding sucralfate (a stomach-lining protectant) to the standard acid-reducer esomeprazole helps heal ulcers that form after a procedure called ESD for early stomach cancer. It helps find which combination works better for recovery.
Hear when a new Early Gastric Cancer or Gastric Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.